Macrophages: Their role, activation and polarization in pulmonary diseases
Open accessThe DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Abstract
Macrophages, circulating in the blood or concatenated into different organs and tissues constitute the first barrier against any disease. They are foremost controllers of both innate and acquired immunity, healthy tissue homeostasis, vasculogenesis and congenital metabolism. Two hallmarks of macrophages are diversity and plasticity due to which they acquire a wobbling array of phenotypes. These phenotypes are appropriately synchronized responses to a variety of different stimuli from either the tissue microenvironment or – microbes or their products. Based on the phenotype, macrophages are classified into classically activated/(M1) and alternatively activated/(M2) which are further sub-categorized into M2a, M2b, M2c and M2d based upon gene expression profiles. Macrophage phenotype metamorphosis is the regulating factor in initiation, progression, and termination of numerous inflammatory diseases. Several transcriptional factors and other factors controlling gene expression such as miRNAs contribute to the transformation of macrophages at different points in different diseases. Understanding the mechanisms of macrophage polarization and modulation of their phenotypes to adjust to the micro environmental conditions might provide us a great prospective for designing novel therapeutic strategy. In view of the above, this review summarises the activation of macrophages, the factors intricated in activation along with benefaction of macrophage polarization in response to microbial infections, pulmonary toxicity, lung injury and other inflammatory diseases such as chronic obstructive pulmonary dysplasia (COPD), bronchopulmonary dysplasia (BPD), asthma and sepsis, along with the existing efforts to develop therapies targeting this facet of macrophage biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 1×
“In case of such pulmonary injury, lung macrophages produce mediators which initiate and perpetuate inflammation along with transformation of mesenchymal cells (Gordon, 2003; Martinez et al., 2008; Mosser and Edwards, 2008).”
BackgroundJaneway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394 · cited 2×
“The type of activation in which LPS acts as a stimulus for in vitro macrophage activation is known as microbial pathogen associated molecular patterns (PAMPs) based activation (Janeway and Medzhitov, 2002; Mukhopadhyay et al., 2004).”
BackgroundThe chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534 · cited 2×
“Depending upon the gene expression profiles, M2 macrophages are further subdivided into 3 subgroups: M2a, M2b, and M2c (Martinez and Gordon, 2014; Martinez et al., 2008; Mantovani et al., 2004) .”
BackgroundMacrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · cited 1×
“This scheme of inflammation is also involved in infection with Salmonella typhi, the initial infection stages of Mycobacterium ulcerans, Mycobacterium avium and Mycobacterium tuberculosis (Sica and Mantovani, 2012).”
BackgroundAlternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269 · cited 2×
“To counterbalance the exorbitant inflammation, macrophages go through apoptosis or transform their phenotype towards M2 type to defend the host from extreme injury and trigger wound healing (Murray and Wynn, 2011).”
BackgroundThe M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689 · cited 8×
“Thus, M1 macrophages are compelling effector cells, highly efficient of producing abundant pro-inflammatory cytokines and exert microbicidal and cytotoxic activities (Martinez and Gordon, 2014; Arango Duque and Descoteaux, 2014) (Fig.”
BackgroundInfluentialMacrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684 · cited 1×
“They respond to these stimuli by initiating an acute inflammatory cascade (Wynn et al., 2013).”
BackgroundAlternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197 · cited 1×
“These markers are known to be involved in immunoregulatory activities such as parasite affliction, tissue remodelling and tumor progression (Gordon and Martinez, 2010).”
Background
Cited by
Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD
Na, Y. R., Stakenborg, M., Seok, S. H., & Matteoli, G. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0172-4 · Cited by 900
M2b macrophage polarization and its roles in diseases
Wang, L.-X., Zhang, S.-X., Wu, H.-J., Rong, X.-L., & Guo, J. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ru1018-378rr · Cited by 884
The Dynamics of the Skin’s Immune System
Nguyen, A. V., & Soulika, A. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081811 · Cited by 694
The Role of Macrophages in the Pathogenesis of ALI/ARDS
Huang, X., Xiu, H., Zhang, S., & Zhang, G. (2018) · Mediators of Inflammation · doi:10.1155/2018/1264913 · Cited by 395
Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments
Xu, J., Ding, L., Mei, J., Hu, Y., Kong, X., Dai, S., Bu, T., Xiao, Q., & Ding, K. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02325-5 · Cited by 389
Metabolic regulation of the immune system in health and diseases: mechanisms and interventions
Hu, T., Liu, C.-H., Lei, M., Zeng, Q., Li, L., Tang, H., & Zhang, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01954-6 · Cited by 383
Macrophages: friend or foe in idiopathic pulmonary fibrosis?
Zhang, L., Wang, Y., Wu, G., Xiong, W., Gu, W., & Wang, C.-Y. (2018) · Respiratory Research · doi:10.1186/s12931-018-0864-2 · Cited by 375
Role of inflammatory cells in airway remodeling in COPD
Wang, Y., Xu, J., Meng, Y., Adcock, I. M., & Yao, X. (2018) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s176122 · Cited by 373
Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis
Iwaszko, M., Biały, S., & Bogunia-Kubik, K. (2021) · Cells · doi:10.3390/cells10113000 · Cited by 311
The Role of Macrophages in the Development of Acute and Chronic Inflammatory Lung Diseases
Lee, J.-W., Chun, W., Lee, H. J., Min, J.-H., Kim, S.-M., Seo, J.-Y., Ahn, K.-S., & Oh, S.-R. (2021) · Cells · doi:10.3390/cells10040897 · Cited by 291
The roles of macrophage polarization in the host immune response to sepsis
Chen, X., Liu, Y., Gao, Y., Shou, S., & Chai, Y. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107791 · Cited by 288
Roles of Macrophage Polarization and Macrophage-Derived miRNAs in Pulmonary Fibrosis
Kishore, A., & Petrek, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.678457 · Cited by 268
Role of Macrophages in Acute Lung Injury and Chronic Fibrosis Induced by Pulmonary Toxicants
Laskin, D. L., Malaviya, R., & Laskin, J. D. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfy309 · Cited by 267
The Macrophage Response Is Driven by Mesenchymal Stem Cell-Mediated Metabolic Reprogramming
Luque-Campos, N., Bustamante-Barrientos, F. A., Pradenas, C., García, C., Araya, M. J., Bohaud, C., Contreras-López, R., Elizondo-Vega, R., Djouad, F., Luz-Crawford, P., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.624746 · Cited by 82
“In response, M1 macrophages increase the secretion of pro-inflammatory mediators such as nitric oxide (NO), tumor necrosis factor-a (TNF)-a, interleukin (IL)-6, IL-15, IL-12, IL-23, IL-1b (21), and additionally increase the ability to present antigens (29).”
BackgroundImmunological distinctions between nonalcoholic steatohepatitis and hepatocellular carcinoma
Koo, S.-Y., Park, E.-J., & Lee, C.-W. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0480-3 · Cited by 47
Cicuéndez, M., Casarrubios, L., Feito, M. J., Madarieta, I., Garcia-Urkia, N., Murua, O., Olalde, B., Briz, N., Diez-Orejas, R., & Portolés, M. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083847 · Cited by 39
Mirata, S., Almonti, V., Di Giuseppe, D., Fornasini, L., Raneri, S., Vernazza, S., Bersani, D., Gualtieri, A. F., Bassi, A. M., & Scarfì, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052840 · Cited by 21
The M2 Macrophages Importance Role in Psoriasis
Alshihmani, A. H. H., Mahmoudi, M., Kheder, R. K., Fadaee, A., & Esmaeili, S. (2025) · Immunity, Inflammation and Disease · doi:10.1002/iid3.70211 · Cited by 16
Extracellular vesicles: emerging therapeutic agents for liver fibrosis
Chiabotto, G., Semnani, A., Ceccotti, E., & Bruno, S. (2025) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2025.08 · Cited by 13
Metadata
- Authors
- Arora, S., Dev, K., Agarwal, B., Das, P., & Syed, M. A.
- Venue
- Immunobiology
- Publisher
- Elsevier BV
- Published
- 2018-04
- Volume
- 223
- Issue
- 4-5
- Pages
- 383-396
- ISSN
- 0171-2985 (ISSN-L)
- OpenAlex
- W2768029258
- Cited by
- 639
- References
- 177
- FWCI
- 10.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.